Ginkgo Bioworks Holdings (DNABW) Change in Acquisitions & Divestments (2021 - 2026)
Ginkgo Bioworks Holdings (DNABW) reported Change in Acquisitions & Divestments of $108.2 million for Q1 2026, down 32.17% quarter-over-quarter from $159.5 million in Q4 2025.
Ginkgo Bioworks Holdings (DNABW) Change in Acquisitions & Divestments (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $108.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $108.2 million; the trailing twelve-month figure through Mar 2026 stood at $267.7 million (changed N/A YoY), and the FY2025 full-year result was $159.5 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $108.2 million, down from $159.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $159.5 million in Q4 2025, with the low at -$65.0 million in Q3 2025.
- Historically, Change in Acquisitions & Divestments has averaged $44.6 million across 3 years, with a median of $32.5 million in 2022.
- The largest YoY upside for Change in Acquisitions & Divestments was 41.41% in 2022 against a maximum downside of 129.13% in 2022.
- Ginkgo Bioworks Holdings' Change in Acquisitions & Divestments stood at -$30000.0 in 2022, then surged by 531710.0% to $159.5 million in 2025, then slumped by 32.17% to $108.2 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $108.2 million (Q1 2026), $159.5 million (Q4 2025), and -$65.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ginkgo Bioworks Holdings | - | - | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.18 Mn |
| Mar 31, 2026 | 108.18 Mn |
| Dec 31, 2025 | 159.48 Mn |
| Dec 31, 2025 | 159.48 Mn |
| Sep 30, 2025 | -64.96 Mn |
| Sep 30, 2025 | -64.96 Mn |
| Jun 30, 2025 | 64.96 Mn |
| Jun 30, 2025 | 64.96 Mn |
| Jun 30, 2022 | -30,000.00 |
| Jun 30, 2022 | -30,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Jun 30, 2021 | 103,000.00 |
| Mar 31, 2021 | 99,000.00 |
| Mar 31, 2021 | 99,000.00 |